• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Vitro Diagnostics

Vitro Diagnostics

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. bioMérieux – Second-Quarter 2016 Business Review

    bioMérieux – Second-Quarter 2016 Business Review

  2. Ximedica acquires Accel Biotech; Creates an Enhanced Offering for Life Science and Biomedical Instrument Product Development and Manufacturing Solutions

    Ximedica acquires Accel Biotech; Creates an Enhanced Offering for Life Science and Biomedical Instrument Product Development and Manufacturing Solutions

  3. bioMérieux enlarges its pathogen identification capability on VITEK® MS

    bioMérieux enlarges its pathogen identification capability on VITEK® MS

  4. bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B.R.A.H.M.S PCT™ Test for Managing Sepsis Patients with Elevated Risk of Mortality

    bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B.R.A.H.M.S PCT™ Test for Managing Sepsis Patients with Elevated Risk of Mortality

  5. Global Companion Diagnostics Strategic Business Report 2016 - Analysis & Forecasts 2015-2022 - Research and Markets

    Global Companion Diagnostics Strategic Business Report 2016 - Analysis & Forecasts 2015-2022 - Research and Markets

  6. Roche Builds a Wide Moat With Dominant Oncology and Diagnostics Franchises

    Firm has a promising strategy of combining expertise in both areas to generate a growing personalized medicine pipeline.

  7. Leader in Genomic Sequencing Illuminates the Way

    Continued technology advancements and market expansion support Illumina's narrow moat.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.